Loading…
Loading…
EQUITY / NASDAQ · XNCM
Baird Medical Investment Holdings Ltd.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →01/01/2025 – 12/31/2025 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗0.7511 USD · 0%
Observed: Oct 2, 2026, 8:00 PM · TickerLayer indicative price; may be delayed
Powered by TickerLayer
10/02/2026 · 0.7511 USD · Volume 48,895
21 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
3 available financial reports
Research reports →SEC FINANCIAL REPORTS
01/01/2025 – 12/31/2025 · Units
| Metric | 2025 / Year end | 2024 / Year end | Change |
|---|---|---|---|
| Revenue | 22,537,016 USD | 37,037,108 USD | -39.15% |
| Operating profit | -25,630,805 USD | 15,315,038 USD | -267.36% |
| Net income | -27,278,005 USD | 12,453,369 USD | -319.04% |
| Operating cash flow | -1,344,032 USD | -6,313,115 USD | — |
| Cash and cash equivalents | 178,321 USD | 2,970,199 USD | -94.00% |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · USD | 2024 / Year end01/01/2024 – 12/31/2024ConsolidatedUnits · USD | 2023 / Year end01/01/2023 – 12/31/2023ConsolidatedUnits · USD |
|---|---|---|---|
| Capital expendituresCash flow statement | 42,315 USD | 2,853,678 USD | 2,638,488 USD |
| Cash and cash equivalentsBalance sheet | 178,321 USD | 2,970,199 USD | — |
| Financing cash flowCash flow statement | -1,393,823 USD | 10,334,146 USD | 3,475,248 USD |
| Gross profitIncome statement | 18,883,738 USD | 32,653,745 USD | 27,230,499 USD |
| Investing cash flowCash flow statement | -42,315 USD | -2,467,043 USD | -2,652,618 USD |
| Net incomeIncome statement | -27,278,005 USD | 12,453,369 USD | 10,545,978 USD |
| Operating cash flowCash flow statement | -1,344,032 USD | -6,313,115 USD | -1,019,964 USD |
| Operating profitIncome statement | -25,630,805 USD | 15,315,038 USD | 11,861,725 USD |
| RevenueIncome statement | 22,537,016 USD | 37,037,108 USD | 31,457,908 USD |
| Total assetsBalance sheet | 69,701,015 USD | 77,962,870 USD | — |
| Total equityBalance sheet | 31,367,631 USD | 39,659,138 USD | 35,706,758 USD |
| Total liabilitiesBalance sheet | 38,477,473 USD | 38,202,392 USD | — |
| Report source | Open report ↗ Published: 07/27/2026 | Open report ↗ Published: 07/27/2026 | Open report ↗ Published: 07/27/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.